On November 10th, the 7th CIIE is coming to an end, and the world's top innovation forces are gathering at the Shanghai National Convention and Exhibition Center, sparking another wave of innovation. As a "full-time student" and "permanent guest" of the CIIE, Johnson&Johnson has been accompanying the CIIE for seven years and has always attached great importance to the CIIE as an important platform for openness, innovation, and cooperation. So far, more than a thousand innovative products have been exhibited through the CIIE, including hundreds of debut products. Among them, orthopedics is one of the key areas for Johnson&Johnson's medical technology business to layout in the Chinese market. At this year's CIIE, the orthopedics business once again showcased several Chinese debut products, hoping to meet the growing health needs of local patients with better products and services.
Looking back at the innovative product layout and exhibition history of Johnson&Johnson Medical Technology Orthopedics, Han Wei, General Manager of Johnson&Johnson Medical Technology Orthopedics Division in China, believes that this is a microcosm of the orthopedic business's deep cultivation in China's innovation hotbed over the past 7 years. Han Wei said, "Having participated in the CIIE for seven consecutive years, Johnson&Johnson Medical Technology Orthopedics once again leads the orthopedic ecosystem with innovative products. The seven Chinese debut products are enough to reflect our product layout throughout the entire life cycle and further demonstrate our determination to constantly break through the boundaries of innovation
According to Han Wei, a total of 11 exhibits from Johnson&Johnson's orthopedic business were showcased at the exhibition booth, including 7 for the first time in China, covering multiple orthopedic health fields such as joint, spine, trauma, maxillofacial, and sports medicine. Johnson&Johnson Medical Technology Orthopedics has long been at the forefront of global orthopedic technology innovation, tracing its source of innovation. It is precisely the increasingly diversified clinical needs of doctors and patients that drive Johnson&Johnson Medical Technology Orthopedics to continuously research technology, materials, and even disease boundaries, creating more personalized solutions for doctors and patients. For example, in the trend of adapting to aging, the first Chinese product Traumacem V+bone cement set exhibited this time considers the need of elderly patients with osteoporosis to improve internal fixation stability, which can effectively reduce postoperative pain, shorten recovery time, and at the same time reduce the risk of postoperative complications and reoperation. In addition to the elderly population, Johnson&Johnson Medical Technology Orthopedics also pays attention to the unique needs of different patient groups. The latest generation of Attune Cementless biological total knee joint system, which was launched in China, takes into account the needs of different patients in its design, providing patients with more durable, stable, and natural knee joints, and better serving young and obese patients in China.
Relying on strong technical strength and forward-looking R&D layout, Johnson&Johnson Medical Technology's orthopedic products are constantly iterating and innovating, and are committed to introducing internationally leading innovative products and technologies into the Chinese market for a long time. Han Wei pointed out that with the help of the "spillover effect" of the CIIE platform, good products can accelerate the benefits to patients. In addition, deepening the local industrial chain and connecting the innovation vitality of the upstream and downstream industries is also a long-term direction for Johnson&Johnson Medical Technology Orthopedics to explore together with the government, institutions, and local partners.
Han Wei believes that in the future, Johnson&Johnson Medical Technology Orthopedics will further deepen local innovation, actively promote the integration and development of local supply chains and industrial chains, break through innovation boundaries with local ecological partners, and create broader imagination space for the future of Chinese orthopedics.